首页     
游客,欢迎您  [登录] [免费注册][忘记密码]
您所在的位置:首页 > 新闻 > Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification
  •   文献已找到:Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification
  • 2022.03.25 | 求助者 :Sun|  人气:201
    文献已找到,AB图书馆

    标题:Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification

    作者:Xiao-Tong Wang

    网址:https://www.dl.begellhouse.com/journals/439f422d0783386a,5fec323e07ab6bc2,2e43e54162073668.html#

    求助者:Sun

    • 求助时间:2022/3/25 9:19:35
    • 求助状态:AB图书馆客服已找到全文,详情咨询在线客服qq 1257749646
    • 文献摘要:
    The TFE3 gene is one of four members of the micropathalima-associated transcription factor family, along with TFEB, TFEC, and MiTF, located on chromosome Xp11.2. The site is notable for its involvement in translocation in Xp11 translocation renal cell carcinoma (RCC) and the mesenchymal counterparts, including Xp11 neoplasm with melanocytic differentiation/TFE3 rearrangement-associated perivascular epithelioid cell tumor (PEComa)/ melanotic Xp11 translocation renal cancer/melanotic Xp11 neoplasm, and alveolar soft-part sarcoma. By morphologic, immunohistochemical, genetic, and prognostic similarities, alveolar soft-part sarcoma with the ASPSCR1-TFE3 gene fusion has a closer relationship with Xp11 neoplasm with melanocytic differentiation/TFE3 rearrangement-associated PEComa/melanotic Xp11 translocation renal cancer/melanotic Xp11 neoplasm. These Xp11 translocation mesenchymal neoplasms may represent a distinct entity, which overlaps with Xp11 translocation RCC and broadens the spectrum of Xp11 translocation-associated neoplasms. The impact of individual fusion variants on specific clinicopathologic features of Xp11 translocation RCC has only recently been described. This review provides insight into the clinicopathologic features, prognosis, treatment, and classification of Xp11 translocation RCC and its mesenchymal counterparts, emphasizing the impact of individual fusion variants on specific clinicopathologic features of Xp11 translocation RCC and the relationships among these Xp11 translocation-associated neoplasms.

    文献《Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, Treatment, and Classification》已经找到全文,详情请咨询在线客服 qq 1257749646。
    如果您还有其他需要寻找全文的文献,请点击文献求助提交

    说明:文献求助是指AB图书馆根据读者的需求,为读者查找论文资料的服务。如果您搜索到相关资料,但不能获取全文,此时便可将有关信息提交求助,由值班客服为您寻找所需文献的全文。提供的文献均来自网络共享资源,不涉及版权交易;如侵犯了您的权利,请告知在线客服,立马删除。文件格式以PDF格式为主。





    客服中心
    帮忙找高难度文献qq1257749646

    有问题咨询我


    文献速递电话

    13613017332


    文献原文传递

    文献全文下载

    文献下载可以找我

    展开客服